These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 37627519

  • 21. Human hepatic in vitro models reveal distinct anti-NASH potencies of PPAR agonists.
    Boeckmans J, Natale A, Rombaut M, Buyl K, Cami B, De Boe V, Heymans A, Rogiers V, De Kock J, Vanhaecke T, Rodrigues RM.
    Cell Biol Toxicol; 2021 Apr; 37(2):293-311. PubMed ID: 32613381
    [Abstract] [Full Text] [Related]

  • 22. Structure of the PPARalpha and -gamma ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family.
    Cronet P, Petersen JF, Folmer R, Blomberg N, Sjöblom K, Karlsson U, Lindstedt EL, Bamberg K.
    Structure; 2001 Aug; 9(8):699-706. PubMed ID: 11587644
    [Abstract] [Full Text] [Related]

  • 23. Non-alcoholic fatty liver disease in type 2 diabetes: Emerging evidence of benefit of peroxisome proliferator-activated receptors agonists and incretin-based therapies.
    Pramanik S, Pal P, Ray S.
    World J Methodol; 2024 Jun 20; 14(2):91319. PubMed ID: 38983664
    [Abstract] [Full Text] [Related]

  • 24. The selective peroxisome proliferator-activated receptor-delta agonist seladelpar reverses nonalcoholic steatohepatitis pathology by abrogating lipotoxicity in diabetic obese mice.
    Haczeyni F, Wang H, Barn V, Mridha AR, Yeh MM, Haigh WG, Ioannou GN, Choi YJ, McWherter CA, Teoh NC, Farrell GC.
    Hepatol Commun; 2017 Sep 20; 1(7):663-674. PubMed ID: 29404484
    [Abstract] [Full Text] [Related]

  • 25. Efficacy of elafibranor in patients with liver abnormalities especially non-alcoholic steatohepatitis: a systematic review and meta-analysis.
    Malik A, Nadeem M, Malik MI.
    Clin J Gastroenterol; 2021 Dec 20; 14(6):1579-1586. PubMed ID: 34370218
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism.
    Kalajdzic T, Faour WH, He QW, Fahmi H, Martel-Pelletier J, Pelletier JP, Di Battista JA.
    Arthritis Rheum; 2002 Feb 20; 46(2):494-506. PubMed ID: 11840453
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH.
    Francque SM, Bedossa P, Ratziu V, Anstee QM, Bugianesi E, Sanyal AJ, Loomba R, Harrison SA, Balabanska R, Mateva L, Lanthier N, Alkhouri N, Moreno C, Schattenberg JM, Stefanova-Petrova D, Vonghia L, Rouzier R, Guillaume M, Hodge A, Romero-Gómez M, Huot-Marchand P, Baudin M, Richard MP, Abitbol JL, Broqua P, Junien JL, Abdelmalek MF, NATIVE Study Group.
    N Engl J Med; 2021 Oct 21; 385(17):1547-1558. PubMed ID: 34670042
    [Abstract] [Full Text] [Related]

  • 31. Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence.
    Cheng HS, Tan WR, Low ZS, Marvalim C, Lee JYH, Tan NS.
    Int J Mol Sci; 2019 Oct 11; 20(20):. PubMed ID: 31614690
    [Abstract] [Full Text] [Related]

  • 32. Novel approach to treat insulin resistance, type 2 diabetes, and the metabolic syndrome: simultaneous activation of PPARalpha, PPARgamma, and PPARdelta.
    Evans JL, Lin JJ, Goldfine ID.
    Curr Diabetes Rev; 2005 Aug 11; 1(3):299-307. PubMed ID: 18220606
    [Abstract] [Full Text] [Related]

  • 33. Crystal Structures of the Human Peroxisome Proliferator-Activated Receptor (PPAR)α Ligand-Binding Domain in Complexes with a Series of Phenylpropanoic Acid Derivatives Generated by a Ligand-Exchange Soaking Method.
    Oyama T, Kamata S, Ishii I, Miyachi H.
    Biol Pharm Bull; 2021 Aug 11; 44(9):1202-1209. PubMed ID: 34471048
    [Abstract] [Full Text] [Related]

  • 34. Elafibranor PPARα/δ Dual Agonist Ameliorates Ovalbumin-Induced Allergic Asthma.
    Lee YE, Im DS.
    Biomol Ther (Seoul); 2024 Jul 01; 32(4):460-466. PubMed ID: 38835138
    [Abstract] [Full Text] [Related]

  • 35. Are fish oil omega-3 long-chain fatty acids and their derivatives peroxisome proliferator-activated receptor agonists?
    Gani OA.
    Cardiovasc Diabetol; 2008 Mar 20; 7():6. PubMed ID: 18355413
    [Abstract] [Full Text] [Related]

  • 36. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH, Chen TH, Lee BH, Hsu YW, Pan TM.
    Food Chem Toxicol; 2014 Feb 20; 64():94-103. PubMed ID: 24275089
    [Abstract] [Full Text] [Related]

  • 37. Structural basis for specific ligation of the peroxisome proliferator-activated receptor δ.
    Wu CC, Baiga TJ, Downes M, La Clair JJ, Atkins AR, Richard SB, Fan W, Stockley-Noel TA, Bowman ME, Noel JP, Evans RM.
    Proc Natl Acad Sci U S A; 2017 Mar 28; 114(13):E2563-E2570. PubMed ID: 28320959
    [Abstract] [Full Text] [Related]

  • 38. Advances and Challenges in Drug Design of PPARδ Ligands.
    Maltarollo VG, Kronenberger T, Windshugel B, Wrenger C, Trossini GHG, Honorio KM.
    Curr Drug Targets; 2018 Mar 28; 19(2):144-154. PubMed ID: 28413978
    [Abstract] [Full Text] [Related]

  • 39. Targeting lipid-sensing nuclear receptors PPAR (α, γ, β/δ): HTVS and molecular docking/dynamics analysis of pharmacological ligands as potential pan-PPAR agonists.
    Mandal SK, Puri S, Kumar BK, Muzaffar-Ur-Rehman M, Sharma PK, Sankaranarayanan M, Deepa PR.
    Mol Divers; 2024 Jun 28; 28(3):1423-1438. PubMed ID: 37280404
    [Abstract] [Full Text] [Related]

  • 40. The pharmacodynamic and differential gene expression analysis of PPAR α/δ agonist GFT505 in CDAHFD-induced NASH model.
    Liu L, Liu C, Zhao M, Zhang Q, Lu Y, Liu P, Yang H, Yang J, Chen X, Yao Y.
    PLoS One; 2020 Jun 28; 15(12):e0243911. PubMed ID: 33326461
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.